Cargando…

Erratum. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90–97

Detalles Bibliográficos
Autores principales: Hampp, Christian, Swain, Richard S., Horgan, Casie, Dee, Elizabeth, Qiang, Yandong, Dutcher, Sarah K., Petrone, Andrew, Tilney, Rong Chen, Maro, Judith C., Panozzo, Catherine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440911/
https://www.ncbi.nlm.nih.gov/pubmed/32647048
http://dx.doi.org/10.2337/dc20-er09a
_version_ 1783573206205988864
author Hampp, Christian
Swain, Richard S.
Horgan, Casie
Dee, Elizabeth
Qiang, Yandong
Dutcher, Sarah K.
Petrone, Andrew
Tilney, Rong Chen
Maro, Judith C.
Panozzo, Catherine A.
author_facet Hampp, Christian
Swain, Richard S.
Horgan, Casie
Dee, Elizabeth
Qiang, Yandong
Dutcher, Sarah K.
Petrone, Andrew
Tilney, Rong Chen
Maro, Judith C.
Panozzo, Catherine A.
author_sort Hampp, Christian
collection PubMed
description
format Online
Article
Text
id pubmed-7440911
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-74409112020-08-27 Erratum. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90–97 Hampp, Christian Swain, Richard S. Horgan, Casie Dee, Elizabeth Qiang, Yandong Dutcher, Sarah K. Petrone, Andrew Tilney, Rong Chen Maro, Judith C. Panozzo, Catherine A. Diabetes Care Errata American Diabetes Association 2020-09 2020-07-09 /pmc/articles/PMC7440911/ /pubmed/32647048 http://dx.doi.org/10.2337/dc20-er09a Text en © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
spellingShingle Errata
Hampp, Christian
Swain, Richard S.
Horgan, Casie
Dee, Elizabeth
Qiang, Yandong
Dutcher, Sarah K.
Petrone, Andrew
Tilney, Rong Chen
Maro, Judith C.
Panozzo, Catherine A.
Erratum. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90–97
title Erratum. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90–97
title_full Erratum. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90–97
title_fullStr Erratum. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90–97
title_full_unstemmed Erratum. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90–97
title_short Erratum. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90–97
title_sort erratum. use of sodium–glucose cotransporter 2 inhibitors in patients with type 1 diabetes and rates of diabetic ketoacidosis. diabetes care 2020;43:90–97
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440911/
https://www.ncbi.nlm.nih.gov/pubmed/32647048
http://dx.doi.org/10.2337/dc20-er09a
work_keys_str_mv AT hamppchristian erratumuseofsodiumglucosecotransporter2inhibitorsinpatientswithtype1diabetesandratesofdiabeticketoacidosisdiabetescare2020439097
AT swainrichards erratumuseofsodiumglucosecotransporter2inhibitorsinpatientswithtype1diabetesandratesofdiabeticketoacidosisdiabetescare2020439097
AT horgancasie erratumuseofsodiumglucosecotransporter2inhibitorsinpatientswithtype1diabetesandratesofdiabeticketoacidosisdiabetescare2020439097
AT deeelizabeth erratumuseofsodiumglucosecotransporter2inhibitorsinpatientswithtype1diabetesandratesofdiabeticketoacidosisdiabetescare2020439097
AT qiangyandong erratumuseofsodiumglucosecotransporter2inhibitorsinpatientswithtype1diabetesandratesofdiabeticketoacidosisdiabetescare2020439097
AT dutchersarahk erratumuseofsodiumglucosecotransporter2inhibitorsinpatientswithtype1diabetesandratesofdiabeticketoacidosisdiabetescare2020439097
AT petroneandrew erratumuseofsodiumglucosecotransporter2inhibitorsinpatientswithtype1diabetesandratesofdiabeticketoacidosisdiabetescare2020439097
AT tilneyrongchen erratumuseofsodiumglucosecotransporter2inhibitorsinpatientswithtype1diabetesandratesofdiabeticketoacidosisdiabetescare2020439097
AT marojudithc erratumuseofsodiumglucosecotransporter2inhibitorsinpatientswithtype1diabetesandratesofdiabeticketoacidosisdiabetescare2020439097
AT panozzocatherinea erratumuseofsodiumglucosecotransporter2inhibitorsinpatientswithtype1diabetesandratesofdiabeticketoacidosisdiabetescare2020439097